Third Pole, Inc.


Third Pole Therapeutics is dedicated to reimagining heart and lung therapy by making life-saving benefits of inhaled nitric oxide accessible on demand worldwide. The company develops innovative cardio-pulmonary therapies, including portable inhaled nitric oxide delivery systems, to treat conditions like pulmonary hypertension and assist in COVID-19 treatment.

Industries

customer-service
hospitality
medical-device

Nr. of Employees

small (1-50)

Third Pole, Inc.

Waltham, Massachusetts, United States, North America


Products

Wearable/tankless inhaled nitric oxide delivery system (portable platform)

A portable, wearable system that generates and delivers inhaled nitric oxide on demand without compressed gas cylinders; intended for neonatal and adult pulmonary hypertension and other respiratory indications.


Services

Strategic collaboration and partnering

Establishing collaborations with pharmaceutical partners for co-development and potential commercialization of inhaled gas therapies.

Clinical development support for early feasibility studies

Support for planning and executing early-stage clinical trials, including feasibility studies and initial patient dosing for device-based inhaled therapies.

Expertise Areas

  • Inhaled nitric oxide therapy delivery
  • Wearable and portable medical device development
  • Gas generation technologies for therapeutic gases
  • Clinical trial management for early feasibility device studies
  • Show More (3)

Key Technologies

  • Pulsed electrical discharge nitric oxide generation
  • Wearable inhaled gas delivery platforms
  • Tankless/portable inhaled gas systems
  • Gas impurity detection and removal techniques
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.